Burn Clinical Trials
Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device
For Specific Compassionate Use Cases
The ReCell® Autologous Cell Harvesting Device is an investigational
product that is being evaluated for use in combination with skin graft
treatments. Use of ReCell is intended to allow the surgeon to use less
harvested skin to create the skin graft, and to help with healing of the
areas where skin is harvested from. This study will evaluate how well
ReCell works in closure of life-threatening burn wounds.
Principal Investigators: Tracee Short, MD and Jeffery Littleton, MD
Status: Currently recruiting participants.
Click here for additional information about this clinical trial.